PCVX

Vaxcyte, Inc.

76.01 USD
+2.14 (+2.90%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Vaxcyte, Inc. stock is up 20.23% since 30 days ago. The next earnings date is Feb 27, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 9 PUTs, 1 CALL.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
26 Jan 16:39 15 Mar, 2024 95.00 PUT 53 8
26 Jan 19:21 15 Mar, 2024 95.00 PUT 27 8
29 Jan 16:12 15 Mar, 2024 65.00 PUT 400 0
29 Jan 20:49 19 Apr, 2024 65.00 PUT 88 0
31 Jan 14:37 19 Jul, 2024 85.00 PUT 12 140
02 Feb 20:12 19 Jul, 2024 65.00 PUT 65 2
02 Feb 20:23 19 Jul, 2024 55.00 PUT 81 1
02 Feb 20:30 19 Jul, 2024 55.00 PUT 200 1
06 Feb 17:58 15 Mar, 2024 70.00 PUT 250 31
21 Feb 20:50 20 Sep, 2024 110.00 CALL 84 0

About Vaxcyte, Inc.

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials. The company was formerly known as SutroVax, Inc.